iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
60 hedge funds and large institutions have $564M invested in iKang Healthcare Group, Inc. in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 10 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
53% more capital invested
Capital invested by funds: $369M → $564M (+$195M)
20% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 10
2% more funds holding
Funds holding: 59 → 60 (+1)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
87% less call options, than puts
Call options by funds: $3.25M | Put options by funds: $24.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$25.6M |
| 2 |
KCMH
Kontiki Capital Management (HK)
Hong Kong
|
+$17.3M |
| 3 |
AC
Athos Capital
Hong Kong
|
+$12.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4M |
| 5 |
SAM
Silphium Asset Management
London,
United Kingdom
|
+$7.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
-$7.63M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$6.67M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$6.15M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$5.77M |
| 5 |
Walleye Trading
New York
|
-$3.79M |
KANG Hedge Fund Activity: Q1 2018 in Review
60 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q1 2018, worth a combined $564M — up 53% from $369M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new KANG positions and 10 closed out — a net gain of 2 holders — while 26 added to existing stakes and 14 trimmed.
The largest buyer was Hillhouse Investment Management, adding an estimated $25.6M. The largest seller was First Manhattan, exiting entirely with an estimated $7.63M sold.
- 60 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q1 2018, up from 59 in Q4 2017.
- Funds reported $564M of iKang Healthcare Group, Inc. stock for Q1 2018, up 53% quarter-over-quarter.
- 12 funds opened new iKang Healthcare Group, Inc. positions in Q1 2018 and 10 closed out, a net change of +2 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q1 2018 was Hillhouse Investment Management, an estimated $25.6M added.
- The largest iKang Healthcare Group, Inc. seller in Q1 2018 was First Manhattan, an estimated $7.63M sold.
Based on aggregated 13F filings for Q1 2018.